A new study in the journal Nutrients found that a new formulation of albutergol may help reduce the risk of heart disease and stroke.
The researchers used a placebo pill and a new version of the drug called albutyrate, which contains a new form of an amino acid that is also found in protein.
They also used a study from the same group that found the drug lowers the risk for developing type 2 diabetes by 33%.
Albuterone also increases blood pressure, cholesterol and triglycerides, according to the study, which was conducted at the Mayo Clinic.
It’s a novel way to treat high blood pressure and heart disease, said Dr. Thomas Burchardt, director of the Mayo Comprehensive Center for Integrative Medicine at Mayo Clinic, in a press release.
The drug is already being tested in trials in patients with heart disease or high blood cholesterol, according a Mayo spokesperson.
But researchers also say the study showed that patients taking albutirate had a lower risk of developing type 1 diabetes.
Albutyrates, which are made from the natural substance, are commonly used to treat depression, anxiety, and migraines.
But in some cases, doctors may prescribe the drug for these conditions, but not all patients respond to the drug, said study co-author Dr. David M. Wray, an assistant professor of cardiology at Emory University in Atlanta.
According to the Mayo study, about 40 percent of the participants taking alandyrate had high blood pressures and 30 percent had high cholesterol.
Alandyrates also have a similar effect on triglycerides.
“Albutyrase is a very powerful inhibitor of the triglyceride biosynthesis pathway and thus, it seems to have a modest but significant effect on the cardiovascular risk of alandirate,” said Drs.
Mary E. Himmelstein and Susan E. DeMarco, who wrote a commentary accompanying the study.
However, the researchers caution that there are no clinical trials yet that would prove this drug is safe and effective in patients.
Dr. M. David Gershman, a cardiologist at the University of Pennsylvania Medical School, told HealthDay, “Our understanding is that the drug may work in a few patients, but there is not enough data to say for sure that it is safe.”
The new formulation, called alvastatin, contains a different form of the same amino acid, which is known to have beneficial effects in patients at high risk of cardiovascular disease.
Dr. Gersdman also said the drug could help people with hypertension and diabetes, but that it should not be used to replace the treatment of high blood glucose.
Researchers are looking at whether the drug will reduce the cardiovascular side effects, including heart attack and stroke, but Dr. Wollenberg says that the benefits have not been seen.
“There are some things that we know about it, and there are some others that are not,” Dr. Walter M. Coughlin, a professor of medicine at Columbia University, told the Associated Press.
What you need to know about heart disease: